Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept.

× No keyword cloud information.

12 in total

1. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.

Authors: A W A M van Rijthoven; J W J Bijlsma; M Canninga-van Dijk; R H W M Derksen; J A G van Roon
Journal: Rheumatology (Oxford) Date: 2006-07-13 Impact factor: 7.580

Review 2. Drug-induced lupus erythematosus.

Authors: Piercarlo Sarzi-Puttini; Fabiola Atzeni; Franco Capsoni; Ennio Lubrano; Andrea Doria
Journal: Autoimmunity Date: 2005-11 Impact factor: 2.815

Review 3. TNFalpha blockade in human diseases: an overview of efficacy and safety.

Authors: Jan Lin; David Ziring; Sheetal Desai; Sungjin Kim; Maida Wong; Yael Korin; Jonathan Braun; Elaine Reed; David Gjertson; Ram Raj Singh
Journal: Clin Immunol Date: 2007-10-04 Impact factor: 3.969

4. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.

Authors: Sreedhar Subramanian; Vijay Yajnik; Bruce E Sands; Garret Cullen; Joshua R Korzenik
Journal: Inflamm Bowel Dis Date: 2011-01 Impact factor: 5.325

Review 5. Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?

Authors: Uta Kiltz; Frank Heldmann; Xenofon Baraliakos; Juergen Braun
Journal: Curr Opin Rheumatol Date: 2012-05 Impact factor: 5.006

6. Update on biologic therapy in the management of axial spondyloarthritis.

Authors: Frank Heldmann; Friedrich Dybowski; Ertan Saracbasi-Zender; Claas Fendler; Jürgen Braun
Journal: Curr Rheumatol Rep Date: 2010-10 Impact factor: 4.592

Review 7. Drug-induced lupus due to anti-tumor necrosis factor alpha agents.

Authors: Michelle F Costa; Nuha R Said; Bernard Zimmermann
Journal: Semin Arthritis Rheum Date: 2007-10-30 Impact factor: 5.532

Review 8. Anti-TNF-induced lupus.

Authors: Emma L Williams; Stephan Gadola; Christopher J Edwards
Journal: Rheumatology (Oxford) Date: 2009-05-04 Impact factor: 7.580

9. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors: Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal: Medicine (Baltimore) Date: 2007-07 Impact factor: 1.889

10. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.

Authors: Michel De Bandt; Jean Sibilia; Xavier Le Loët; Sebastian Prouzeau; Bruno Fautrel; Christian Marcelli; Eric Boucquillard; Jean Louis Siame; Xavier Mariette
Journal: Arthritis Res Ther Date: 2005-03-01 Impact factor: 5.156

2 in total

Review 1. A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?

Authors: Tânia Santiago; Mariana Galante Santiago; João Rovisco; Cátia Duarte; Armando Malcata; José António Pereira da Silva
Journal: Clin Rheumatol Date: 2013-08-17 Impact factor: 2.980

Review 2. Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.

Authors: Ora Shovman; Shalev Tamar; Howard Amital; Abdulla Watad; Yehuda Shoenfeld
Journal: Clin Rheumatol Date: 2017-10-23 Impact factor: 2.980

2 in total